[Statlist] Announcement of the Basel Epidemiology Seminar (BES) / Basel Biometric Society (BBS) meeting on Patient Preferences; November 22, 2018

[Blatna, Bibiana]

Dear All

We would like to announce the first joint meeting of the Basel Epidemiology Seminar (BES) and the Basel Biometric Society (BBS) on "Patient Preferences - methods and relevance for medicinal decision making".
The meeting will take place on November 22, 14:00 -17:00, in Building 683-0B110 of Basel,  F. Hoffmann-la Roche AG, Viaduktstrasse 33, CH-4051 Basel (nearby Basel SBB railway station).

We are proud to invite you to a meeting with contributions from industry and academia to discuss this new methodological approach in drug development.

If you are interested in participating please visit our website and register until November 21: http://bes.ceb-institute.org/2018/07/16/upcoming-seminars/

Kind regards,
Conny Berlin

On behalf of the organizational committee
Daniel Rosenberg (Actelion), Uli Burger (Roche), Fred Sorenson (Xcenda), Conny Berlin (Novartis)


Conny Berlin
Global Head Quantitative Safety & Epidemiology

Fon         +41 61 32 48736
Mobile    +41 798451615
conny.berlin using novartis.com<mailto:conny.berlin using novartis.com>

Novartis International AG
Chief Medical Office - Patient Safety
Novartis Campus
WSJ 27.3.91
4056 Basel
Switzerland


-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://stat.ethz.ch/pipermail/statlist/attachments/20181001/f3cc0609/attachment.html>